Citation

Walter T. Hughes, Wayne M. Dankner, Ram Yogev, Sharon Huang, Mary E. Paul, Midnela Acevedo Flores, Mark W. Kline, Lee-Jen Wei. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.. Clinical Infectious Diseases. 2005. 40: 136-45.

Citation

Andrea Kovacs, Mary K. Cowles, Paula Britto, Edmund Capparelli, Mary Glenn Fowler, Rita J. Jeremy, John ( Jack ) Moye, Kenneth McIntosh, Mobeen H. Rathore, Jane Pitt, Robert Husson. Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to ZDV during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.. Pediatric Infectious Disease Journal. 2005. 24: 503-509.

Citation

Akihiko Saitoh, K. K. Singh, Christine Powell, Terence Fenton, Courtney V. Fletcher, Richard Brundage, Stuart E. Starr, Stephen A. Spector. An MDRI-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children.. AIDS. 2005. 19: 371-80.

Citation

Sharon Appelbaum Nachman, Philimon Gona, Wayne M. Dankner, Adriana Weinberg, Ram Yogev, Anne A. Gershon, Mobeen H. Rathore, Jennifer S. Read, Sharon Huang, Carol Elgie, Kimberly Hudgens, Walter T. Hughes. The rate of serious bacterial infection among HIV-infected children with immune reconstitution who have discontinued Opportunistic Infection prophylaxis.. Pediatrics. 2005. 115: e488-e494.

Citation

Howard Max Rosenblatt, Kenneth Stanley, Lin-Ye Song, George M. Johnson, Andrew A. Wiznia, Paul Krogstad, Sharon Appelbaum Nachman, Andrew A. Wiznia, Paul Krogstad, Sharon Appelbaum Nachman. Immunological Response to Highly Active Antiretroviral Therapy in Children with Clinically Stable HIV-1 Infection.. Journal of Infectious Diseases. 2005. 192: 445-55.

Citation

Ellen Gould Chadwick, John H. Rodman, Paula Britto, Christine Powell, Paul Palumbo, Katherine Luzuriaga, Michael Hughes, Elaine J. Abrams, Patricia M. Flynn, William Borkowsky, Ram Yogev. Ritonavir-Based Highly Active Antiretroviral Therapy In HIV-1 Infected Infants 24 Months of Age.. Pediatric Infectious Disease Journal. 2005. 24: 793 - 800.

Citation

Deborah S. Storm, Mary D. Boland, Steven Gortmaker, Yan He, Joan H. Skurnick, Lois C. Howland, James M. Oleske. Protease inhibitor combination therapy, severity of illness, and quality of life in children with perinatally acquired HIV-1 infection. Pediatrics. 2005. 115: e173-e182.

Citation

Mark Mirochnick, Alice M. Stek, Midnela Acevedo, Margaret A. Keller, Diane Holland, Edmund Capparelli, James D. Connor, Sharon Huang, Michael Hughes, Lynne M. Mofenson, Yvonne J. Bryson. Safety and pharmacokinetics of nelfinavir co-administered with zidovudine and lamivudine in infants during the first 6 weeks of life. Journal of Acquired Immune Deficiency Syndromes. 2005. 39: 189-194.

Citation

John S. Lambert, Daniel Johnson, Elizabeth (Betsy) J. McFarland, Petronella Muresan, Terence Fenton, James McNamara, Jennifer S. Read, Elizabeth Hawkins, Pamela Bouquin, Scharla Estep, Georgia D. Tomaras, Carol A. Vincent, Mobeen H. Rathore, Ann J. Melvin, Sanjay Gurunathan. Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.. Journal of Infectious Diseases. 2005. 192: 2129-2133.

Citation

John S. Lambert, John ( Jack ) Moye, Susan Plaeger, E. Richard Stiehm, James Bethel, Lynne M. Mofenson, Bonnie J. Mathieson, Jonathan Kagan, Howard Max Rosenblatt, Helene M.A. Paxton, Hildie Suter, Alan Landay. Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.. Clinical and Diagnostic Laboratory Immunology. 2005. 12: 622-631.